PHATHOM PHARMACEUTICALS INC (PHAT) Stock Cash Flow
NASDAQ:PHAT - Nasdaq - US71722W1071 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -345.79M | -334.33M | -201.59M | -197.72M | -143.88M | |||
| Depreciation Amortization | 758.00K | 795.00K | 575.00K | 620.00K | 520.00K | |||
| Change In Working Capital | 24.88M | 30.81M | 11.08M | 19.52M | -27.32M | |||
| Interest Paid | 18.78M | 17.29M | 11.13M | 7.03M | 4.07M | |||
| Other non cash items | 37.47M | 35.95M | 52.35M | 31.06M | 22.22M | |||
| OPERATING CASH FLOW | -282.68M | -266.77M | -137.58M | -146.53M | -148.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -113.00K | -135.00K | -1.63M | -1.04M | -330.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -113.00K | -135.00K | -1.63M | -1.04M | -330.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 49.50M | 59.40M | 211.99M | 95.45M | 42.76M | |||
| Stock Issued/Repurchased | N/A | 123.37M | 155.59M | 24.60M | 1.94M | |||
| FINANCING CASH FLOW | 172.87M | 182.77M | 367.58M | 120.04M | 44.71M | |||
| CHANGE IN CASH | -109.92M | -84.13M | 228.37M | -27.53M | -104.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -282.68M | -266.77M | -137.58M | -146.53M | -148.46M | |||
| Capital Expenditure | -113.00K | -135.00K | -1.63M | -1.04M | -330.00K | |||
| FREE CASH FLOW | -282.79M | -266.90M | -139.21M | -147.57M | -148.79M | |||
All data in USD